Top Markets
Coin of the day
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
株式のランク #17262
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
株価
$0.8799
最終同期: 2026-09-01
時価総額
$259.22M
変化(1日)
-7.85%
変化(1年)
-14.57%
US
取引 Invivyd, Inc. (IVVD)

カテゴリー

Invivyd, Inc.(IVVD)の株価履歴
終値の最高値: $0.85 (2026-09-01)

終値の最安値: $27.68 (2021-08-01)
Invivyd, Inc. の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -37.40%
2025 355.72%
2024 -79.42%
2023 46.08%
2022 -91.63%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$550.65 37.32%
US
$1.05K 48.27%
NL
$148.50 513.89%
US
$122.21 -10.03%
AU
$763.69 9.05%
CH